These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8516549)

  • 1. [IgD myeloma: an aggressive variant. Description of a clinical case and review of the literature].
    Airoldi M; Pelucco L; Lamperti R; Gioia F
    Recenti Prog Med; 1993 Jun; 84(6):423-7. PubMed ID: 8516549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
    Takemori N; Kondo K; Kawamura T; Imai K; Sakurai H; Sato T
    Am J Hematol; 2001 Jan; 66(1):62-3. PubMed ID: 11426497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rare clinical forms of multiple myeloma].
    Golenkov AK
    Ter Arkh; 1994; 66(12):90-2. PubMed ID: 7900059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoglobulin D lambda multiple myeloma: a case report].
    Qiao SK; Zhang XJ; Wang FX; Pan L; Yao L; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):643-6. PubMed ID: 17605885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.
    Chepovetsky J; Chari A; Jagannath S; Ramanthan L
    Clin Chim Acta; 2013 Oct; 425():233-5. PubMed ID: 23954772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic amyloidosis associated with IgD-λ multiple myeloma].
    Nagamachi Y; Yamauchi N; Muramatsu H; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Kikuchi S; Hirako T; Kitaoka K; Ono K; Ihara H; Kato J
    Rinsho Ketsueki; 2011 Dec; 52(12):1888-92. PubMed ID: 22241157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgD-λ multiple myeloma with excessive excretion of free light chains: a diagnostic trap in the identification of monoclonal gammopathies.
    Zahir H; Tali A; Rachidi M; Mouhib H; Daif H; Ait Ouzdi Z; Haouach K; Chabaa L
    Ann Biol Clin (Paris); 2019 Feb; 77(1):107-111. PubMed ID: 30799291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations of multiple myeloma: relation to class and type M component.
    Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):896-7. PubMed ID: 817790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
    Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
    Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple myeloma with D immunoglobulin].
    Benchekroun L; Ouzzif Z; Bouabdillah M; Jaouhar N; Aoufir F; Aoufi F; Chabraoui L
    Ann Biol Clin (Paris); 2011; 69(5):581-7. PubMed ID: 22008139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgD paraproteinemias.
    Tichý M; Matĕja F; Urban P; Matuska M
    Neoplasma; 1993; 40(1):59-61. PubMed ID: 8350950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodiagnosis of IgD multiple myeloma. A report of 17 cases.
    Chernokhvostova EV; Batalova TN; German GP; Andreyeva NE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):539-52. PubMed ID: 6170548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A further case of IgD myeloma (author's transl)].
    Daunizeau A; Daunizeau A; Comyn F
    Sem Hop; 1979 Dec 8-15; 55(41-42):1941-3. PubMed ID: 231320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgD myeloma: immunology and ultrastructure.
    Ioachim NJ; McKenna PJ; Halperin I; Chung FJ
    Ann Clin Lab Sci; 1978; 8(3):209-18. PubMed ID: 418730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IgD/kappa myeloma].
    Golenkov AK; German GP; Zlatkina AR; Chernokhvostova EV; Cheredeev AN
    Ter Arkh; 1984; 56(11):129-31. PubMed ID: 6441298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgD plasma cell neoplasia: clinical manifestations and characteristic features.
    Pruzanski W; Rother I
    Can Med Assoc J; 1970 May; 102(10):1061-5. PubMed ID: 5000054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary amyloidosis associated with IgD-lambda M-proteinemia].
    Kimura S; Iwatsuka R; Aoki T; Odawara J; Asada N; Yamakura M; Takeuchi M; Matsue K
    Rinsho Ketsueki; 2007 Dec; 48(12):1555-8. PubMed ID: 18203516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term complete remission in IgD-myeloma.
    Bemelmans RH; van Toorn DW; van Leeuwen L; Schaar CG
    Eur J Haematol; 2006 Apr; 76(4):339-41. PubMed ID: 16519706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.